We are live on ! Find out more
C

Covestor Portfolio holdings

AUM $173M
1-Year Est. Return 56.91%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
+56.91%
3 Year Est. Return
+135.94%
5 Year Est. Return
10 Year Est. Return
AUM
$160M
AUM Growth
+$166K
Cap. Flow
-$423K
Cap. Flow %
-0.26%
Top 10 Hldgs %
10.2%
Holding
2,896
New
82
Increased
1,507
Reduced
896
Closed
98

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Industrials 13.06%
3 Financials 12.72%
4 Healthcare 10.01%
5 Consumer Discretionary 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MXCT icon
2551
MaxCyte
MXCT
$119M
$0 ﹤0.01%
5
+4
+400% +$15
MXL icon
2552
MaxLinear
MXL
$6.14B
$0 ﹤0.01%
8
+4
+100% +$64
NAT icon
2553
Nordic American Tanker
NAT
$1.57B
$0 ﹤0.01%
23
+2
+10% +$6
NAUT icon
2554
Nautilus Biotechnolgy
NAUT
$122M
$0 ﹤0.01%
8
+1
+14% +$2
NBR icon
2555
Nabors Industries
NBR
$1.31B
$0 ﹤0.01%
1
NBTB icon
2556
NBT Bancorp
NBTB
$2.69B
$0 ﹤0.01%
6
+1
+20% +$48
NC icon
2557
NACCO Industries
NC
$299M
$0 ﹤0.01%
6
+3
+100% +$89
NEO icon
2558
NeoGenomics
NEO
$2.26B
$0 ﹤0.01%
14
+4
+40% +$62
NFBK
2559
DELISTED
Northfield Bancorp
NFBK
$0 ﹤0.01%
14
-22
-61% -$274
NEXT icon
2560
NextDecade
NEXT
$2B
$0 ﹤0.01%
18
+1
+6% +$6
NG icon
2561
NovaGold Resources
NG
$3.14B
$0 ﹤0.01%
29
+2
+7% +$7
NGVT icon
2562
Ingevity
NGVT
$2.32B
$0 ﹤0.01%
3
+2
+200% +$83
NKSH icon
2563
National Bankshares
NKSH
$273M
$0 ﹤0.01%
12
-6
-33% -$181
NKTR icon
2564
Nektar Therapeutics
NKTR
$2.34B
0
NL icon
2565
NLI Holdings
NL
$342M
$0 ﹤0.01%
38
+6
+19% +$47
NLOP
2566
Net Lease Office Properties
NLOP
$161M
$0 ﹤0.01%
10
NMRA icon
2567
Neumora Therapeutics
NMRA
$195M
$0 ﹤0.01%
10
-3
-23% -$36
NMRK icon
2568
Newmark Group
NMRK
$2.57B
$0 ﹤0.01%
10
-784
-99% -$11.6K
NN icon
2569
NextNav
NN
$2.58B
$0 ﹤0.01%
12
+1
+9% +$13
NNI icon
2570
Nelnet
NNI
$4.53B
$0 ﹤0.01%
1
NOVA
2571
DELISTED
Sunnova Energy
NOVA
$0 ﹤0.01%
14
+1
+8% +$5
NPO icon
2572
Enpro
NPO
$6.06B
$0 ﹤0.01%
1
NRC icon
2573
NRC Health Common Stock
NRC
$488M
$0 ﹤0.01%
25
-434
-95% -$8.23K
NRIX icon
2574
Nurix Therapeutics
NRIX
$2.67B
$0 ﹤0.01%
5
NUVB icon
2575
Nuvation Bio
NUVB
$2.1B
$0 ﹤0.01%
36
+2
+6% +$5

Similar funds

Covestor's Q4 2024 Portfolio in Review

As of Q4 2024, Covestor held 2,896 positions worth $160M, up 0.1% from $160M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Covestor's Q4 2024 filing shows 82 new, 1,507 increased, 896 reduced and 98 closed positions. Its largest new stake was Nebius Group N.V.: 11,908 shares worth $330K. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $1.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Financials.

  • Covestor's largest Q4 2024 buy was Nebius Group N.V.: 11,908 shares worth $330K.
  • Covestor added most to TeraWulf in Q4 2024, an estimated $509K increase.
  • Covestor's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $1.3M.
  • Covestor fully exited Vector Group Ltd. in Q4 2024, selling an estimated $230K.
  • Covestor's ten largest holdings make up 10% of its $160M portfolio in Q4 2024.
  • Covestor opened 82 new positions and closed 98 in Q4 2024.
  • Covestor's portfolio value rose 0.1% quarter-over-quarter to $160M.

Based on Covestor's 13F filing for Q4 2024, filed 13 Feb 2025.